Home
K2 HealthVentures Equity Trust reported a 5.6% stake in Alto Neuroscience ANRO · 1,617,855 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.6%
- Last report
- First report
- Shares held
- 1,617,855 sh
- Class
- Common Stock, $0.0001 par value per share
- Event date
- 25/01/13
- Filed
- 25/05/15
First 5%+ report · 5.6% stake
Alto Neuroscience trades, last 26 weeks
What else happened in Alto Neuroscience around then
Filed or reported within 30 days of the trade day · 24/12/14~25/02/12K2 HealthVentures Equity Trust's other 5% stake reports
- K2 HealthVentures Equity Trust
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
3.1% stake
5,790,453 sh
3.1% stake
Filed 05/15
- K2 HealthVentures Equity Trust
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
5.01% stake
8,997,035 sh
5.01% stake
Filed 02/17
- K2 HealthVentures Equity Trust
5% stakeAlto Neuroscience
5% stakeAlto Neuroscience
ANRO
2.4% stake
788,995 sh
2.4% stake
Filed 02/17
- K2 HealthVentures Equity Trust
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
6.6% stake
11,397,310 sh
6.6% stake
Filed 25/08/11
